CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and in Combination With NA-831 in Healthy Volunteers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04480333
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:38.529334+00:00
Published At: 2020-07-21T00:00:00+00:00
Record Updated At: 2020-07-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Covid19", "Corona Virus Infection", "Severe Acute Respiratory Syndrome", "Severe Acute Respiratory Infection", "Severe Acute Respiratory Syndrome (SARS) Pneumonia", "Severe Acute Respiratory Syndrome of Upper Respiratory Tract", "Neurodegeneration", "Neuroinflammatory Response"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-07-21"
protocolSection.identificationModule.nctId: "NCT04480333"
protocolSection.identificationModule.officialTitle: "A Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and in Combination With NA-831 in Healthy Volunteers"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.